Avalere Spotlight: Life Sciences in 2014
Summary
The 2014 market will be characterized by challenge and transformation across payers, providers, and patients which will create pressures for the pharmaceutical and medical device industries to:
Please note: This is an archived post. Some of the information and data discussed in this article may be out of date. It is preserved here for historical reference but should not be used as the basis for business decisions. Please see our main Insights section for more recent posts.
-
- Devise new selling strategies in anticipation of the bleed of new exchange products into commercial benefit designs.
-
- Adapt organizational and field capabilities to bring evidence-based solutions and new contracting arrangements to integrated providers who may play a more dominant role in regional markets.
-
- Invest in and partner to generate real-world evidence, analytics, and tools that can support clinical decision-making.
-
- Revisit patient support strategies to be responsive to growing cost burdens on patients and new health plan messaging.
Click the button below to download the full Avalere Spotlight Life Sciences report. For more information on how Avalere can partner with you to position your business for success in 2014, please contact Reginald Williams.